Literature DB >> 6402249

Gall stone dissolving agents.

I A Bouchier.   

Abstract

During the decade in which the medical dissolution of gall stones has become feasible several drugs have been introduced but only the two listed in the British National Formulary have been intensively evaluated and shown to be effective--chenodeoxycholic acid and the closely allied ursodeoxycholic acid. The dissolution of gall stones was last reviewed in the "BMF" in 1976, at which stage experience with chenodeoxycholic acid was limited. Since then the indications and potential for this bile acid in treating gall stones have become better understood, and data on the newly introduced ursodeoxycholic acid are being evaluated. Cholesterol, but not pigment, gall stones are amenable to oral dissolution treatment. This review will cover firstly, chenodeoxycholic acid, secondly, ursodeoxycholic acid, then a comparison of the two drugs, an assessment of the place of medical dissolution in the management of gall stones, and, finally, the dissolution of stones in the common bile duct.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402249      PMCID: PMC1547017          DOI: 10.1136/bmj.286.6367.778

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Mondor's disease. A superficial phlebitis of the breast.

Authors:  M C OLDFIELD
Journal:  Lancet       Date:  1962-05-12       Impact factor: 79.321

2.  Diseases of the alimentary system. Gall stones.

Authors:  I A Bouchier
Journal:  Br Med J       Date:  1976-10-09

3.  Prevention of eczema.

Authors:  D J Matthew; B Taylor; A P Norman; M W Turner
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

4.  House dust mite sensitivity in childhood asthma.

Authors:  J O Warner; J F Price
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

Review 5.  The medical treatment of gallstones.

Authors:  I A Bouchier
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

6.  Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.

Authors:  P N Maton; J H Iser; A Reuben; H M Saxton; G M Murphy; R H Dowling
Journal:  Medicine (Baltimore)       Date:  1982-03       Impact factor: 1.889

7.  Neonatal birch-pollen contact and subsequent allergy to birch pollen.

Authors:  F Björkstén; I Suoniemi; V Koski
Journal:  Clin Allergy       Date:  1980-09

8.  Intraductal infusion of mono-octanoin: experience in 24 patients with retained common-duct stones.

Authors:  L N Jarrett; T W Balfour; G D Bell; D R Knapp; D H Rose
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

  8 in total
  2 in total

1.  The composition of gallstones from Irish patients.

Authors:  S C Mulligan; P Kennelly; O I Corrigan
Journal:  Ir J Med Sci       Date:  1984-03       Impact factor: 1.568

2.  Stones in the common bile duct: experience with medical dissolution therapy.

Authors:  K W Somerville; W R Ellis; B H Whitten; T W Balfour; G D Bell
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.